Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.
about
Coenzyme Q10 for heart failureCoenzyme Q10 for heart failureAgents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyondLevosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVEChemerin as an independent predictor of cardiovascular event riskEffect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trialsRole of the Lebanese family caregivers in cardiac self-care: a collective approachALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analysesAge-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.Vasodilator therapy with hydralazine induces angiotensin AT receptor-mediated cardiomyocyte growth in mice lacking guanylyl cyclase-A.Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failureCardio-Oncology: Cancer Therapy-related Cardiovascular Complications in a Molecular Targeted Era: New Concepts and Perspectives.Social status, health-related quality of life, and event-free survival in patients with heart failure.Nesiritide in acute decompensated heart failure: current status and future perspectivesPain and heart failure: unrecognized and untreated.Tolvaptan: the evidence for its therapeutic value in acute heart failure syndromeHealth literacy and the patient with heart failure--implications for patient care and research: a consensus statement of the Heart Failure Society of America.DEFEAT - Heart Failure: a guide to management of geriatric heart failure by generalist physicians.Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure.Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failureA combined aerobic and resistance exercise program improves physical functional performance in patients with heart failure: a pilot studyCombined aerobic and resistance exercise program improves task performance in patients with heart failure.Tissue Doppler time intervals predict the occurrence of rehospitalization in chronic heart failure: data from the daunia heart failure registry.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with theBiomarkers of myocardial stress and systemic inflammation in patients who engage in heart failure self-care management.Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionalsManagement of hypertension in high-risk ethnic minority with heart failure.Evolution of biomarker guided therapy for heart failure: current concepts and trial evidence.Weight and mortality following heart failure hospitalization among diabetic patients.Reproducibility in echocardiographic assessment of diastolic function in a population based study (the STANISLAS Cohort study)The underuse of digoxin in heart failure, and approaches to appropriate use.Referral and use of heart failure clinics: what factors are related to use?Arterial-ventricular coupling with aging and diseasePatients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) - Polish population.Prospective care of heart failure in Japan: lessons from CHART studies.Effectiveness of telemedicine and distance learning applications for patients with chronic heart failure. A protocol for prospective parallel group non-randomised open label study.Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group.Cardiac resynchronization therapy: a practical guide for patient management after device implantation, part II.Short-term trends in heart failure-related hospitalizations in a high-risk state.Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem?
P2860
Q24194154-2F4089CC-1D15-41A9-B6EC-3A7F4A788D5DQ24235690-76809675-C6F3-4699-83D5-0E901C9F7693Q24645066-E01023C6-BD65-458C-B2DD-EFC40BCCFFB5Q24650903-C750C328-2110-4016-8CC3-C83E8EBE8BF9Q26752472-1F42B6B1-F53A-4620-930F-BADAA02FD37DQ26851606-CDAE6502-6B5E-4A82-B78B-48E715CB9090Q28386667-9462ED0E-09D1-414E-BFCA-4C48B146CA82Q33576830-2EFB3D0E-6BB0-4642-A6FE-0131360AC00BQ33655983-8E76D64C-9E8F-4584-BB95-35534628BA21Q33730624-F58C9ACE-9DFB-4490-BA31-470EAC16222FQ33799392-79F0BA89-577D-46D3-A03F-8163D6A1717AQ33807542-F678C0E5-86EC-466E-B301-A1665CAFADCEQ33855082-500DAA99-9A47-474D-987F-050DE43EF0CEQ33878162-6C64242C-CC06-4701-8EA9-F9BA55CADA1EQ33900159-B578B2AE-EC33-4C90-8112-A660B2C4B57EQ33973976-16AD34D4-81C3-44CB-9C3A-F4A182EAA17EQ34019475-53208C8E-C4B3-4980-8A85-111404BBD154Q34038879-94FDB0FB-12C4-47F2-BF93-10FC70D7B4C5Q34051055-615C9CD6-65E3-43BD-B607-E527D58D1B75Q34068712-A720CA17-0A94-49A7-8F97-B2236FB3D628Q34084205-E33474DD-1FB7-43BE-BEB5-C35BD4737975Q34084220-5F2DB1B6-7111-4CA4-985F-EF58B61C7DE7Q34284188-2A610709-CA99-4B49-BA83-1FFBA4C9DD55Q34830023-0FE3EC13-9496-4945-A63B-782D0974918EQ35043024-7E1C50E3-12EC-41A7-A9A7-18502214E199Q35054950-5BFE20EE-5B9B-4209-88CD-995A273EC559Q35071345-0966526F-540A-4C21-9CCE-45FA71C80269Q35139977-BDC5892C-F43F-4467-8747-61F217502878Q35178168-42024FCD-C611-4950-846B-63BFE9CC35DFQ35324234-C3EF5886-AA7A-4991-85C4-B195D6584F99Q35640965-F12EAF16-073E-44B4-BCD4-2D16E90BFA4FQ35828261-B996220F-2307-4B71-B791-C6EDD91BC7A0Q35939295-2E96355F-74C7-4E28-974C-B13A3329E8F8Q35992082-988EC8B1-5128-4121-8E46-8D9E4CD84937Q36118031-47A8A52D-1C8B-4FEC-854D-C5840EA55090Q36306979-7B1214E3-25CB-4A8D-BBE3-04A6910678E1Q36485216-5EEAACA5-60E8-4957-811A-7ACC8177A5F7Q36559184-CAA1D5A0-07AF-41D3-A9AD-8EE4C3E844C7Q36589613-9C2DD20A-A1A1-4768-85C0-6AB7FC6CD3A6Q36596985-F1ADB015-9262-49A7-A463-F09C0DE6026E
P2860
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.
@ast
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.
@en
type
label
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.
@ast
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.
@en
prefLabel
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.
@ast
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.
@en
P1476
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.
@en
P2093
Heart Failure Society Of America
P356
10.1016/J.CARDFAIL.2005.12.001
P577
2006-02-01T00:00:00Z